Cannabics
Pharmaceuticals is an emerging pharmaceutical development company whose
flagship product is Cannabics SR, a medical cannabis capsule specifically
designed as a palliative care treatment for cancer patients. The company’s
proprietary SR technology provides ten to twelve hours of steady-state,
beneficial therapeutic effects and, consequently, allows for a convenient oral,
once-per-day dosing regimen for patients.
Cannabics
has been preparing to launch its line of SR products in eligible states of the
US and EU markets under existing medical cannabis regulatory policies. The
company is also now in its final stage of planning a series of formal clinical
studies intended to demonstrate the unique medical benefits its products
provide to patients suffering from various ailments.
In the
first week of November 2014, Cannabics confirmed that it had executed an IP
Licensing and Collaboration Agreement with Kalapa Holding, a leading medical
cannabis provider and distributor in Spain, whose offerings include a diverse
line of medical cannabinoid based products. The Cannabics-Kalapa agreement will
guide the production and distribution of Cannabics SR products within the
Spanish market.
In strict
compliance with Spanish laws and regulations, Cannabics SR medical cannabis
products will be available to certified patients only through a regulated
Spanish entity and affiliate of Kalapa Holding, the Asociacion Centro Cannabico
de Terapias Naturales. The products will be locally manufactured from pure
extracts produced from high quality, organic medical cannabis strains by KSK
Labs, another Kalapa Holding affiliate.
In
collaborating with Kalapa Holding, Cannabics will unite the advanced
cannabinoid administration technology implanted in its line of products with
Kalapa’s operational capabilities and wide reach within the Spanish medical
cannabis market. Management’s hope is that this synergy, which will allow
Cannabics to offer its unique advanced products to European patients for the
very first time, signals only the beginning of a long-lasting and successful
partnership.
Cannabics
Pharmaceuticals is focused on developing and marketing sophisticated drugs,
therapies, food supplements and administration routes based on the active
ingredients found in unique strains of the cannabis plant.
For more
information, visit www.cannabics.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign up
for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The
Quality Stocks Daily Blog http://blog.qualitystocks.net
The
Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The
Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see
disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment